Apollomics COO gets 5K shares, 8K stock options
Apollomics Inc. (APLM) reported that director and Chief Operating Officer Chen Yi-Kuei had 5,000 restricted stock units vest on September 15, 2026, converting into 5,000 Class A Ordinary Shares held directly, bringing his direct holdings to 20,100 shares.
Rhea-AI Filing Summary
Apollomics Inc. (APLM) reported that director and Chief Operating Officer Chen Yi-Kuei had 5,000 restricted stock units vest on September 15, 2026, converting into 5,000 Class A Ordinary Shares held directly, bringing his direct holdings to 20,100 shares. On September 14, 2026 he was also granted a stock option for 8,000 shares at $23.18 per share under the 2023 Incentive Award Plan, vesting in two equal installments in 2027. In addition, 121,248 Class A Ordinary Shares are reported as held indirectly through Maxpro Investment Co., Ltd., with beneficial ownership disclaimed except to the extent of his pecuniary interest. No Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F3, F4 | 5,000 | $0.00 | $0.00 |
| Exercise | CLASS A ORDINARY SHARES | 5,000 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) F2 | 8,000 | $0.00 | $0.00 |
| holding | CLASS A ORDINARY SHARES F1 | -- | -- | -- |
Footnotes (4)
- F1. The reporting person is a member of the Board of Directors of Maxpro Investment Co., Ltd. and is co-founder and managing director of Maxpro Ventures Ltd. The amount reported includes a 100 share adjustment for shares previously owned but inadvertently omitted. Excludes 3,823 Class A Ordinary Shares issuable upon the exercise of warrants held directly by Maxpro Investment Co., Ltd., which were previously reported on the Form 3 filed March 18, 2026 and the Form 3/A filed April 14, 2026. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- F2. The stock option was granted under the Apollomics Inc. 2023 Incentive Award Plan on September 14, 2026. The option vests and becomes exercisable over a one-year period: fifty percent (50%) of the shares subject to the option vest on March 14, 2027 (six months from the grant date), and the remaining fifty percent (50%) vest on September 14, 2027 (twelve months from the grant date), subject to the reporting person's continued service to the Issuer through each applicable vesting date.
- F3. Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share
- F4. RSUs were granted and previously reported on a Form 3 filed March 18, 2026 and a Form 3/A filed April 14, 2026. Of the initial RSU grant, 5,000 shares vested on each of February 9, 2026, March 15, 2026, June 15, 2026 and September 15, 2026. This transaction represents the vesting of 5,000 RSUs on September 15, 2026.
Key Figures
Key Terms
Restricted Stock Units financial
Stock Option (Right to Buy) financial
Incentive Award Plan financial
pecuniary interest financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Apollomics (APLM) COO Chen Yi-Kuei receive in this Form 4?
What indirect Apollomics (APLM) holdings are reported for Chen Yi-Kuei?
How do the new Apollomics (APLM) stock options for Chen Yi-Kuei vest?
Were Chen Yi-Kuei’s Apollomics (APLM) transactions made under a Rule 10b5-1 trading plan?
What RSU activity did Apollomics (APLM) report for Chen Yi-Kuei on September 15, 2026?
AI-generated analysis. How Rhea-AI works. Not financial advice.